Clinical Trials Directory

Trials / Conditions / Proteus Syndrome

Proteus Syndrome

5 registered clinical trials studyying Proteus Syndrome — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingMK-7075 (Miransertib) in Proteus Syndrome
NCT04316546
National Human Genome Research Institute (NHGRI)Phase 2
CompletedDose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
NCT02594215
National Human Genome Research Institute (NHGRI)Phase 1
CompletedInformed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
NCT01369953
National Human Genome Research Institute (NHGRI)—
RecruitingStudy of Proteus Syndrome and Related Congenital Disorders
NCT00001403
National Human Genome Research Institute (NHGRI)—
No Longer AvailableExpanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies
NCT03317366
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)—